Elad Gilboa, Ph.D. - Publications

Affiliations: 
2014 Electrical Engineering Washington University, Saint Louis, St. Louis, MO 
Area:
Computer Engineering, Electronics and Electrical Engineering

8/161 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Strappini F, Gilboa E, Pitzalis S, Kay K, McAvoy M, Nehorai A, Snyder AZ. Adaptive smoothing based on Gaussian processes regression increases the sensitivity and specificity of fMRI data. Human Brain Mapping. PMID 27943516 DOI: 10.1002/Hbm.23464  0.481
2015 Gilboa E, Saatci Y, Cunningham JP. Scaling Multidimensional Inference for Structured Gaussian Processes. Ieee Transactions On Pattern Analysis and Machine Intelligence. 37: 424-36. PMID 26353252 DOI: 10.1109/Tpami.2013.192  0.353
2014 Gilboa E, Cunningham JP, Nehorai A, Gruev V. Image interpolation and denoising for division of focal plane sensors using Gaussian processes. Optics Express. 22: 15277-91. PMID 24977618 DOI: 10.1364/Oe.22.015277  0.476
2014 Gilboa E, Cunningham JP, Nehorai A, Gruev V. GP-grid image interpolation and denoising for division of focal plane sensors Proceedings of Spie - the International Society For Optical Engineering. 9099. DOI: 10.1117/12.2050615  0.484
2013 Yang P, Chavali P, Gilboa E, Nehorai A. Parallel load schedule optimization with renewable distributed generators in smart grids Ieee Transactions On Smart Grid. 4: 1431-1441. DOI: 10.1109/Tsg.2013.2264728  0.444
2013 Gilboa E, Chavali P, Yang P, Nehorai A. Distributed optimization via adaptive regularization for large problems with separable constraints Icassp, Ieee International Conference On Acoustics, Speech and Signal Processing - Proceedings. 3287-3291. DOI: 10.1109/ICASSP.2013.6638266  0.467
2012 Gilboa E, La Rosa PS, Nehorai A. Estimating electrical conductivity tensors of biological tissues using microelectrode arrays. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2012: 1040-4. PMID 23366073 DOI: 10.1109/EMBC.2012.6346112  0.489
2012 Gilboa E, La Rosa PS, Nehorai A. Estimating electrical conductivity tensors of biological tissues using microelectrode arrays. Annals of Biomedical Engineering. 40: 2140-55. PMID 22581477 DOI: 10.1007/S10439-012-0581-9  0.507
Low-probability matches (unlikely to be authored by this person)
2019 Dalal G, Gilboa E, Mannor S, Wehenkel L. Chance-Constrained Outage Scheduling Using a Machine Learning Proxy Ieee Transactions On Power Systems. 34: 2528-2540. DOI: 10.1109/Tpwrs.2018.2889237  0.277
2013 Gilboa E, Saatçi Y, Cunningham JP. Scaling Multidimensional Inference for Structured Gaussian Processes. Ieee Transactions On Pattern Analysis and Machine Intelligence. PMID 24101326 DOI: 10.1109/TPAMI.2013.192  0.255
1985 Gilboa E. Trends in American attitudes toward the PLO and the palestinians Political Communication. 3: 45-67. DOI: 10.1080/10584609.1986.9962781  0.124
2015 Hoinka J, Berezhnoy A, Dao P, Sauna ZE, Gilboa E, Przytycka TM. Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery. Nucleic Acids Research. 43: 5699-707. PMID 25870409 DOI: 10.1093/Nar/Gkv308  0.11
1986 Gilboa E. Retrovirus vectors and their uses in molecular biology Bioessays. 5: 252-257. PMID 3551938 DOI: 10.1002/bies.950050605  0.102
2004 Liao X, Li Y, Bonini C, Nair S, Gilboa E, Greenberg PD, Yee C. Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 757-64. PMID 15120337 DOI: 10.1016/J.Ymthe.2004.02.011  0.099
1998 Morse MA, Lyerly HK, Gilboa E, Thomas E, Nair SK. Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells. Cancer Research. 58: 2965-8. PMID 9679955  0.098
2005 Gilboa E. Media-broker diplomacy: When journalists become mediators Critical Studies in Media Communication. 22: 99-120. DOI: 10.1080/07393180500071998  0.096
1979 Gilboa E. Educating Israeli Officers in the Processes of Peacemaking in the Middle East Conflict Journal of Peace Research. 16: 155-162. DOI: 10.1177/002234337901600205  0.096
1989 Hantzopoulos PA, Sullenger BA, Ungers G, Gilboa E. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector Proceedings of the National Academy of Sciences of the United States of America. 86: 3519-3523. PMID 2542934 DOI: 10.1073/Pnas.86.10.3519  0.095
2016 Gilboa E, Jumbert MG, Miklian J, Robinson P. Moving media and conflict studies beyond the CNN effect Review of International Studies. 1-19. DOI: 10.1017/S026021051600005X  0.088
1992 Suchi M, Dinur T, Desnick RJ, Gatt S, Pereira L, Gilboa E, Schuchman EH. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: Correction of the metabolic defect in cultured Niemann-Pick disease cells Proceedings of the National Academy of Sciences of the United States of America. 89: 3227-3231. PMID 1565614 DOI: 10.1073/Pnas.89.8.3227  0.085
2000 Gilboa E. Mass communication and diplomacy: A theoretical framework Communication Theory. 10: 275-309.  0.084
1999 Nair S, Wearsch PA, Mitchell DA, Wassenberg JJ, Gilboa E, Nicchitta CV. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides. Journal of Immunology (Baltimore, Md. : 1950). 162: 6426-32. PMID 10352256  0.083
2007 Melhem NM, Liu XD, Boczkowski D, Gilboa E, Barratt-Boyes SM. Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag. European Journal of Immunology. 37: 2164-73. PMID 17615585 DOI: 10.1002/Eji.200636782  0.083
1990 Sullenger BA, Lee TC, Smith CA, Ungers GE, Gilboa E. Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to moloney murine leukemia virus replication Molecular and Cellular Biology. 10: 6512-6523. PMID 2247070 DOI: 10.1128/Mcb.10.12.6512  0.081
1991 Fetten JV, Roy N, Gilboa E. A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes Journal of Immunology. 147: 2697-2705. PMID 1717574  0.08
1994 Gilboa E, Smith C. Gene therapy for infectious diseases: the AIDS model Trends in Genetics. 10: 139-144. PMID 7913251 DOI: 10.1016/0168-9525(94)90216-X  0.079
1998 Gilboa E. Media diplomacy: Conceptual divergence and applications Harvard International Journal of Press/Politics. 3: 56-75.  0.078
1993 Bordignon C, Mavilio F, Ferrari G, Servida P, Ugazio AG, Notarangelo LD, Gilboa E. Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID Human Gene Therapy. 4: 513-520. PMID 8399494 DOI: 10.1089/Hum.1993.4.4-513  0.076
2006 Hess PR, Boczkowski D, Nair SK, Snyder D, Gilboa E. Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Cancer Immunology, Immunotherapy : Cii. 55: 672-83. PMID 16133108 DOI: 10.1007/s00262-005-0064-z  0.075
2012 Berezhnoy A, Brenneman R, Bajgelman M, Seales D, Gilboa E. Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition. Molecular Therapy. Nucleic Acids. 1: e51. PMID 23344651 DOI: 10.1038/mtna.2012.41  0.074
1991 Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation Journal of Virology. 65: 6811-6816. PMID 1942253 DOI: 10.1128/Jvi.65.12.6811-6816.1991  0.074
1982 Gilboa E, Kolbe M, Noonan K, Kucherlapati R. Construction of a mammalian transducing vector from the genome of Moloney murine leukemia virus. Journal of Virology. 44: 845-51. PMID 7176018 DOI: 10.1128/Jvi.44.3.845-851.1982  0.074
2013 Gilboa E, McNamara J, Pastor F. Use of oligonucleotide aptamer ligands to modulate the function of immune receptors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1054-62. PMID 23460536 DOI: 10.1158/1078-0432.CCR-12-2067  0.074
2009 Gilboa E. Media and conflict resolution The Sage Handbook of Conflict Resolution. 455-474. DOI: 10.4135/9780857024701.n23  0.073
2013 Gilboa E, Saatçi Y, Cunningham JP. Scaling multidimensional gaussian processes using projected additive approximations 30th International Conference On Machine Learning, Icml 2013. 454-461.  0.073
1987 Rasmussen JA, Gilboa E. Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector Journal of Virology. 61: 1368-1374. PMID 3573142  0.073
1996 Staats HF, Porgador A, Faiola B, Gilboa E, Palker TJ. Induction of cytotoxic T lymphocytes (CTL) specific for HIV-1 or protection against tumor challenge by intranasal immunization with CTL peptide and cholera toxin Faseb Journal. 10: A1191.  0.072
1998 Mitchell DA, Nair SK, Gilboa E. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells. European Journal of Immunology. 28: 1923-33. PMID 9645374 DOI: 10.1002/(SICI)1521-4141(199806)28:06<1923::AID-IMMU1923>3.0.CO;2-9  0.072
2002 Shohet IM, Puterman M, Gilboa E. Deterioration patterns of building cladding components for maintenance management Construction Management and Economics. 20: 305-314. DOI: 10.1080/01446190210125563  0.072
2005 Gilboa E. Global television news and foreign policy: Debating the CNN effect International Studies Perspectives. 6: 325-341. DOI: 10.1111/j.1528-3577.2005.00211.x  0.07
1999 Nair SK, Hull S, Coleman D, Gilboa E, Lyerly HK, Morse MA. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. International Journal of Cancer. Journal International Du Cancer. 82: 121-4. PMID 10360830 DOI: 10.1002/(SICI)1097-0215(19990702)82:1<121::AID-IJC20>3.0.CO;2-X  0.069
2005 Fassnacht M, Lee J, Milazzo C, Boczkowski D, Su Z, Nair S, Gilboa E. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5566-71. PMID 16061874 DOI: 10.1158/1078-0432.CCR-05-0699  0.068
1997 Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. International Journal of Cancer. Journal International Du Cancer. 70: 706-15. PMID 9096653 DOI: 10.1002/(Sici)1097-0215(19970317)70:6<706::Aid-Ijc13>3.0.Co;2-7  0.068
1987 Armentano D, Yu SF, Kantoff PW, von Ruden T, Anderson WF, Gilboa E. Effect of internal viral sequences on the utility of retroviral vectors Journal of Virology. 61: 1647-1650. PMID 3033290  0.068
1992 Li M, Hantzopoulos PA, Banerjee D, Zhao SC, Schweitzer BI, Gilboa E, Bertino JR. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors Human Gene Therapy. 3: 381-390. PMID 1525211 DOI: 10.1089/hum.1992.3.4-381  0.067
2010 Pastor F, Kolonias D, Giangrande PH, Gilboa E. Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature. 465: 227-30. PMID 20463739 DOI: 10.1038/Nature08999  0.067
1997 Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. The Journal of Experimental Medicine. 186: 1177-82. PMID 9314567 DOI: 10.1084/Jem.186.7.1177  0.066
1984 Hwang LHS, Gilboa E. Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection Journal of Virology. 50: 417-424. PMID 6200606  0.066
1979 Baltimore D, Gilboa E, Rothenberg E, Yoshimura F. Production of a discrete, infectious, double-stranded DNA by reverse transcription in virions of Moloney murine leukemia virus Cold Spring Harbor Symposia On Quantitative Biology. 43: 869-874. PMID 90578 DOI: 10.1101/Sqb.1979.043.01.093  0.066
1992 Lee TC, Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells New Biologist. 4: 66-74. PMID 1536832  0.065
2003 Zhao Y, Boczkowski D, Nair SK, Gilboa E. Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity. Blood. 102: 4137-42. PMID 12920018 DOI: 10.1182/blood-2003-06-1867  0.065
2009 Zhou J, Soontornworajit B, Martin J, Sullenger BA, Gilboa E, Wang Y. A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling. Macromolecular Bioscience. 9: 831-5. PMID 19434675 DOI: 10.1002/Mabi.200900046  0.064
1993 Smith C, Muench MO, Knizewski M, Gilboa E, Moore MAS. Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia Leukemia. 7: 310-317. PMID 8426483  0.063
1998 McCowage GB, Phillips KL, Gentry TL, Hull S, Kurtzberg J, Gilboa E, Smith C. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. Experimental Hematology. 26: 288-98. PMID 9546311  0.063
2005 Lee J, Fassnacht M, Nair S, Boczkowski D, Gilboa E. Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Research. 65: 11156-63. PMID 16322266 DOI: 10.1158/0008-5472.CAN-05-2805  0.063
1990 Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity Journal of Experimental Medicine. 172: 1217-1224. PMID 2212951  0.062
1990 Gansbacher B, Bannerji R, Daniels B, Cronin K, Gilboa E, Zier K. Retroviral Vector-mediated γ-Interferon Gene Transfer into Tumor Cells Generates Potent and Long Lasting Antitumor Immunity Cancer Research. 50: 7820-7825. PMID 2123742  0.062
1993 Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E. Regression of bladder tumors in mice treated with interleukin 2 gene- modified tumor cells Journal of Experimental Medicine. 177: 1127-1134. PMID 8459207  0.062
1994 Bannerji R, Arroyo CD, Cordon-Cardo C, Gilboa E. The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity Journal of Immunology. 152: 2324-2332. PMID 7907636  0.061
2003 Gilboa E. Television News and U.S. Foreign Policy: Constraints of Real-Time Coverage Harvard International Journal of Press/Politics. 8: 97-113. DOI: 10.1177/1081180X03256576  0.061
1985 Taketo M, Gilboa E, Sherman MI. Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the Moloney murine leukemia virus long terminal repeat Proceedings of the National Academy of Sciences of the United States of America. 82: 2422-2426. PMID 3857593  0.061
1990 Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication Cell. 63: 601-608. PMID 2225067 DOI: 10.1016/0092-8674(90)90455-N  0.061
1977 Prives C, Gilboa E, Revel M, Winocour E. Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen. Proceedings of the National Academy of Sciences of the United States of America. 74: 457-61. PMID 191809 DOI: 10.1073/Pnas.74.2.457  0.06
2013 Gilboa E. Expression of new antigens on tumor cells by inhibiting nonsense-mediated mRNA decay. Immunologic Research. 57: 44-51. PMID 24198064 DOI: 10.1007/s12026-013-8442-7  0.06
2011 Pastor F, Kolonias D, McNamara JO, Gilboa E. Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1878-86. PMID 21829171 DOI: 10.1038/mt.2011.145  0.06
2014 Berezhnoy A, Castro I, Levay A, Malek TR, Gilboa E. Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity. The Journal of Clinical Investigation. 124: 188-97. PMID 24292708 DOI: 10.1172/Jci69856  0.059
1996 Nair SK, Snyder D, Gilboa E. Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo. Journal of Immunology (Baltimore, Md. : 1950). 156: 1772-80. PMID 8596026  0.059
1998 Roberts JE, Gilboa E, Gotlib IH. Ruminative response style and vulnerability to episodes of dysphoria: Gender, neuroticism, and episode duration Cognitive Therapy and Research. 22: 401-423. DOI: 10.1023/A:1018713313894  0.059
2000 Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Research. 60: 1028-34. PMID 10706120  0.058
1994 Vieweg J, Heston WDW, Gilboa E, Fair WR. An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer Prostate. 24: 291-298. PMID 8208623 DOI: 10.1002/pros.2990240604  0.058
1985 Keller G, Paige C, Gilboa E, Wagner EF. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors Nature. 318: 149-154. PMID 3903518 DOI: 10.1038/318149A0  0.057
1975 Gilboa E, Prives CL, Aviv H. Purification of SV-40 messenger RNA by hybridization to SV-40 DNA covalently bound to sepharose Biochemistry. 14: 4215-4220. PMID 170957  0.057
2002 Faiola B, Doyle C, Gilboa E, Nair S. Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells. Immunology. 105: 47-55. PMID 11849314 DOI: 10.1046/j.0019-2805.2001.01343.x  0.057
1998 Gilboa E. Secret diplomacy in the television age International Communication Gazette. 60: 211-225. DOI: 10.1177/0016549298060003001  0.057
1994 Vieweg J, Bannerji R, Rosenthal FM, Heston WDW, Fair WR, Gansbacher B, Gilboa E. Immunotherapy of Prostate Cancer in the Dunning Rat Model: Use of Cytokine Gene Modified Tumor Vaccines Cancer Research. 54: 1760-1765. PMID 8137291  0.056
1996 Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. The Journal of Experimental Medicine. 184: 465-72. PMID 8760800  0.056
1980 Shoemaker C, Goff S, Gilboa E, Paskind M, Mitra SW, Baltimore D. Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proceedings of the National Academy of Sciences of the United States of America. 77: 3932-6. PMID 6449003 DOI: 10.1073/pnas.77.7.3932  0.056
1979 Gilboa E. Studying mass media roles: The use of simulation in national and international politics Teaching Political Science. 7: 73-88. DOI: 10.1080/00922013.1979.11000185  0.055
2002 Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature. 418: 252-8. PMID 12110902 DOI: 10.1038/418252A  0.055
1989 Von Ruden T, Gilboa E. Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA Journal of Virology. 63: 677-682. PMID 2463378  0.053
1993 Porgador A, Gansbacher B, Bannerji R, Tzehoval E, Gilboa E, Feldman M, Eisenbach L. Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells International Journal of Cancer. 53: 471-477. PMID 8428800 DOI: 10.1002/Ijc.2910530320  0.053
2000 Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Platt JL. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. Journal of Immunology (Baltimore, Md. : 1950). 165: 1599-604. PMID 10903769  0.053
2008 Gilboa E. Searching for a theory of public diplomacy Annals of the American Academy of Political and Social Science. 616: 55-77. DOI: 10.1177/0002716207312142  0.053
1998 Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnology. 16: 364-9. PMID 9555728 DOI: 10.1038/nbt0498-364  0.052
1999 Gilboa E. The makings of a tumor rejection antigen. Immunity. 11: 263-70. PMID 10514004 DOI: 10.1016/S1074-7613(00)80101-6  0.052
1979 Gilboa E, Mitra SW, Goff S, Baltimore D. A detailed model of reverse transcription and tests of crucial aspects. Cell. 18: 93-100. PMID 509527 DOI: 10.1016/0092-8674(79)90357-X  0.05
1997 Nair SK, Boczkowski D, Snyder D, Gilboa E. Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. European Journal of Immunology. 27: 589-97. PMID 9079797 DOI: 10.1002/eji.1830270304  0.05
1994 Zhao SC, Li MX, Banerjee D, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR. Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase Cancer Gene Therapy. 1: 27-33. PMID 7621235  0.05
1981 Shoemaker C, Goff S, Gilboa E, Paskind M, Mitra SW, Baltimore D. Structure of cloned retroviral circular DNAs: implications for virus integration. Cold Spring Harbor Symposia On Quantitative Biology. 45: 711-7. PMID 6266763 DOI: 10.1101/Sqb.1981.045.01.089  0.049
1984 Champoux JJ, Gilboa E, Baltimore D. Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase Journal of Virology. 49: 686-691. PMID 6199510 DOI: 10.1128/Jvi.49.3.686-691.1984  0.049
2014 Wilson AG, Gilboa E, Nehorai A, Cunningham JP. Fast kernel learning for multidimensional pattern extrapolation Advances in Neural Information Processing Systems. 4: 3626-3634.  0.049
1980 Goff SP, Gilboa E, Witte ON, Baltimore D. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell. 22: 777-85. PMID 6257398 DOI: 10.1016/0092-8674(80)90554-1  0.048
1994 Li MX, Banerjee D, Zhao SC, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR. Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction Blood. 83: 3403-3408. PMID 8193378  0.047
1985 Eglitis MA, Kantoff P, Gilboa E, Anderson WF. Gene expression in mice after high efficiency retroviral-mediated gene transfer Science. 230: 1395-1398. PMID 2999985  0.047
1979 Gilboa E, Goff S, Shields A, Yoshimura F, Mitra S, Baltimore D. In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus. Cell. 16: 863-74. PMID 88264 DOI: 10.1016/0092-8674(79)90101-6  0.047
1993 Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells Journal of Immunology. 150: 1458-1470. PMID 8432988  0.047
1977 Gilboa E, Soreq H, Aviv H. Initiation of RNA synthesis in isolated nuclei European Journal of Biochemistry. 77: 393-400. PMID 560967 DOI: 10.1111/J.1432-1033.1977.TB11679.X  0.047
2003 Santulli-Marotto S, Nair SK, Rusconi C, Sullenger B, Gilboa E. Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Cancer Research. 63: 7483-9. PMID 14612549  0.046
1994 Lee SW, Gallardo HF, Gilboa E, Smith C. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. Journal of Virology. 68: 8254-64. PMID 7966618  0.045
1998 Gilboa E, Nair SK, Lyerly HK. Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunology, Immunotherapy : Cii. 46: 82-7. PMID 9558003 DOI: 10.1007/s002620050465  0.045
2005 Gilboa E. The CNN effect: The search for a communication theory of international relations Political Communication. 22: 27-44. DOI: 10.1080/10584600590908429  0.044
2004 Gilboa E. Knocking the SOCS1 off dendritic cells. Nature Biotechnology. 22: 1521-2. PMID 15583655 DOI: 10.1038/nbt1204-1521  0.044
1997 Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. Journal of Immunology (Baltimore, Md. : 1950). 158: 834-41. PMID 8993001  0.044
2008 Dollins CM, Nair S, Boczkowski D, Lee J, Layzer JM, Gilboa E, Sullenger BA. Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer. Chemistry & Biology. 15: 675-82. PMID 18635004 DOI: 10.1016/J.Chembiol.2008.05.016  0.044
1976 Gilboa E, Aviv H. Preferential synthesis of viral late RNA by nuclei isolated from SV40 lytically infected cells Cell. 7: 567-573. PMID 182375 DOI: 10.1016/0092-8674(76)90207-5  0.044
1996 Porgador A, Snyder D, Gilboa E. Induction of antitumor immunity using bone marrow-generated dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 156: 2918-26. PMID 8609412  0.044
1998 Mitchell DA, Nair SK, Gilboa E. Correction: Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells (European Journal of Immunology (1998) 28, 6 (1923-1933)) European Journal of Immunology. 28: 3891.  0.044
1984 Hwang LS, Park J, Gilboa E. Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA. Molecular and Cellular Biology. 4: 2289-97. PMID 6096692  0.044
2004 Gilboa E, Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunological Reviews. 199: 251-63. PMID 15233739 DOI: 10.1111/j.0105-2896.2004.00139.x  0.043
1981 Goff SP, Witte ON, Gilboa E, Rosenberg N, Baltimore D. Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells. Journal of Virology. 38: 460-8. PMID 6264122 DOI: 10.1128/Jvi.38.2.460-468.1981  0.043
1995 Vieweg J, Gilboa E. Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. Cancer Investigation. 13: 193-201. PMID 7874574 DOI: 10.3109/07357909509011690  0.043
2000 Larchian WA, Horiguchi Y, Nair SK, Fair WR, Heston WD, Gilboa E. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 2913-20. PMID 10914741  0.043
2014 Shemesh M, Gilboa E, Ben-Gal TS, Zilberman M. Controlled release of analgesic drugs from porous bioresorbable structures for various biomedical applications. Journal of Biomaterials Science. Polymer Edition. 25: 410-30. PMID 24313726 DOI: 10.1080/09205063.2013.863748  0.042
1986 Wolff L, Mushinski JF, Gilboa E, Morse HC. Induction of hematopoietic tumors using a viral construct containing c-myc cDNA from normal mouse spleen Current Topics in Microbiology and Immunology. 132: 33-39. PMID 3024920 DOI: 10.1007/978-3-642-71562-4_5  0.041
1995 Porgador A, Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. The Journal of Experimental Medicine. 182: 255-60. PMID 7540653 DOI: 10.1084/jem.182.1.255  0.04
1978 Groner Y, Gilboa E, Aviv H. Methylation and capping of RNA polymerase II primary transcripts by HeLa nuclear homogenates Biochemistry. 17: 977-982. PMID 629955 DOI: 10.1021/Bi00599A005  0.04
2007 Gilboa E. DC-based cancer vaccines. The Journal of Clinical Investigation. 117: 1195-203. PMID 17476349 DOI: 10.1172/JCI31205  0.04
1979 Mitra SW, Goff S, Gilboa E, Baltimore D. Synthesis of a 600-nucleotide-long plus-strand DNA by virions of Moloney murine leukemia virus. Proceedings of the National Academy of Sciences of the United States of America. 76: 4355-9. PMID 92028 DOI: 10.1073/Pnas.76.9.4355  0.04
1999 Gilboa E. How tumors escape immune destruction and what we can do about it. Cancer Immunology, Immunotherapy : Cii. 48: 382-5. PMID 10501851 DOI: 10.1007/s002620050590  0.039
1994 Saito S, Bannerji R, Gansbacher B, Rosenthal FM, Romanenko P, Heston WD, Fair WR, Gilboa E. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Research. 54: 3516-20. PMID 8012975  0.039
2015 Schrand B, Berezhnoy A, Brenneman R, Williams A, Levay A, Gilboa E. Reducing toxicity of 4-1BB costimulation: targeting 4-1BB ligands to the tumor stroma with bi-specific aptamer conjugates. Oncoimmunology. 4: e970918. PMID 25949891 DOI: 10.4161/21624011.2014.970918  0.039
2014 Gilboa E. Induction of Tumor Immunity by Targeted Inhibition of Nonsense-Mediated mRNA Decay Current Cancer Research. 12: 67-82. DOI: 10.1007/978-1-4614-8809-5_5  0.038
1994 Gilboa E, Lyerly HK, Vieweg J, Saito S. Immunotherapy of cancer using cytokine gene-modified tumor vaccines. Seminars in Cancer Biology. 5: 409-17. PMID 7703440  0.038
1988 Hwang LH, Gilboa E. Intron sequences may influence the efficiency and correctness in selecting a 3'-splicing acceptor site Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association. 87: 1141-1148. PMID 3252000  0.038
2014 Hoinka J, Berezhnoy A, Sauna ZE, Gilboa E, Przytycka TM. AptaCluster - A Method to Cluster HT-SELEX Aptamer Pools and Lessons from its Application. Research in Computational Molecular Biology : ... Annual International Conference, Recomb ... : Proceedings. Recomb (Conference : 2005-). 8394: 115-128. PMID 25558474 DOI: 10.1007/978-3-319-05269-4_9  0.037
2012 Gilboa E. mRNA leapfrogs DNA to show promise for therapeutic gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 694-5. PMID 22472978 DOI: 10.1038/mt.2012.31  0.036
1981 Gilboa E. The use of simulation in combatting terrorism Terrorism. 5: 265-279. DOI: 10.1080/10576108108435514  0.036
1995 Smith C, Lee SW, Gilboa E. Inhibition of HIV-1 with intracellular immunization with RNA decoys Advanced Drug Delivery Reviews. 17: 369-371. DOI: 10.1016/0169-409X(95)00073-G  0.035
2007 Nair S, Boczkowski D, Fassnacht M, Pisetsky D, Gilboa E. Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Research. 67: 371-80. PMID 17210720 DOI: 10.1158/0008-5472.CAN-06-2903  0.034
2014 Berezhnoy A, Rajagopalan A, Gilboa E. A clinically useful approach to enhance immunological memory and antitumor immunity. Oncoimmunology. 3: e28811. PMID 25057446 DOI: 10.4161/onci.28811  0.034
1988 Gilboa E. Retroviral gene transfer: applications to human therapy Advances in Experimental Medicine and Biology. 241: 29-33. PMID 2464908  0.032
1975 Prives CL, Aviv H, Gilboa E, Revel M, Winocour E. The cell-free translation of SV40 messenger RNA. Cold Spring Harbor Symposia On Quantitative Biology. 39: 309-16. PMID 169074 DOI: 10.1101/Sqb.1974.039.01.041  0.031
1995 Lee SW, Gilboa E, Smith C. Inhibition of HIV-1 with minimal Rev responsive element (RRE) decoys International Antiviral News. 3: 89-90.  0.031
1986 Gilboa E, Eglitis MA, Kantoff PW, Anderson WF. Transfer and expression of cloned genes using retroviral vectors Biotechniques. 4: 504-512.  0.031
2012 Blankenstein T, Coulie PG, Gilboa E, Jaffee EM. The determinants of tumour immunogenicity. Nature Reviews. Cancer. 12: 307-13. PMID 22378190 DOI: 10.1038/Nrc3246  0.03
1996 Gilboa E. Immunotherapy of cancer with genetically modified tumor vaccines. Seminars in Oncology. 23: 101-7. PMID 8607020  0.03
2000 Thornburg C, Boczkowski D, Gilboa E, Nair SK. Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 23: 412-8. PMID 10916750 DOI: 10.1097/00002371-200007000-00004  0.029
1986 Anderson WF, Kantoff PW, Eglitis MA, Gilboa E. Gene transfer into animals by retroviral vectors Basic Life Sciences. 37: 59-65. PMID 3010936  0.028
1995 Lee SW, Gallardo HF, Gaspar O, Smith C, Gilboa E. Inhibition of HIV-1 in CEM cells by a potent TAR decoy. Gene Therapy. 2: 377-84. PMID 7584112  0.027
1996 Phillips K, Gentry T, McCowage G, Gilboa E, Smith C. Cell-surface markers for assessing gene transfer into human hematopoietic cells. Nature Medicine. 2: 1154-6. PMID 8837618 DOI: 10.1038/nm1096-1154  0.026
1985 Wagner EF, Keller G, Gilboa E, Rüther U, Stewart C. Gene transfer into murine stem cells and mice using retroviral vectors Cold Spring Harbor Symposia On Quantitative Biology. 50: 691-700. PMID 3868504 DOI: 10.1101/Sqb.1985.050.01.085  0.025
1998 Lee SW, Gilboa E. High level accumulation of an aberrantly spliced human DHFR RNA species. Molecules and Cells. 8: 189-200. PMID 9638651  0.025
2015 Gilboa E, Berezhnoy A, Schrand B. Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery. Cancer Immunology Research. 3: 1195-200. PMID 26541880 DOI: 10.1158/2326-6066.CIR-15-0194  0.024
2003 Nair S, Boczkowski D, Moeller B, Dewhirst M, Vieweg J, Gilboa E. Synergy between tumor immunotherapy and antiangiogenic therapy. Blood. 102: 964-71. PMID 12689940 DOI: 10.1182/blood-2002-12-3738  0.024
1972 Gilboa E, Pines A, Solomon L. The Wizardry of Change Agents The Journal of Applied Behavioral Science. 8: 351-360. DOI: 10.1177/002188637200800308  0.024
2001 Gilboa E. The risk of autoimmunity associated with tumor immunotherapy. Nature Immunology. 2: 789-92. PMID 11526387 DOI: 10.1038/ni0901-789  0.023
1975 Prives C, Gilboa E, Aviv H, Revel M, Winocour E. Proceedings: Purification and translation of mRNA coding for SV40 proteins. Israel Journal of Medical Sciences. 11: 1206. PMID 173683  0.023
2002 Gilboa E. Global communication and foreign policy Journal of Communication. 52: 731-748. DOI: 10.1093/joc/52.4.731  0.023
2004 Gilboa E. The promise of cancer vaccines. Nature Reviews. Cancer. 4: 401-11. PMID 15122211 DOI: 10.1038/nrc1359  0.021
2006 Gilboa E. Media and international conflict The Sage Handbook of Conflict Communication: Integrating Theory, Research, and Practice. 595-626. DOI: 10.4135/9781412976176.n22  0.016
1995 Vieweg J, Gilboa E. Gene therapy approaches in urologic oncology. Surgical Oncology Clinics of North America. 4: 203-18. PMID 7796281  0.015
1973 Gilboa E, Elkana Y, Rigbi M. Purification and Properties of Human Acrosin European Journal of Biochemistry. 39: 85-92. PMID 4770802 DOI: 10.1111/j.1432-1033.1973.tb03106.x  0.014
1989 Gilboa E. American media messages and public opinion on the Palestinian uprising Political Communication. 6: 191-202. DOI: 10.1080/10584609.1989.9962873  0.014
1997 Gilboa E, Gotlib IH. Cognitive Biases and Affect Persistence in Previously Dysphoric and Never-dysphoric Individuals Cognition and Emotion. 11: 517-538.  0.013
2016 Gilboa E. Public opinion and Obama's foreign policy Us Foreign Policy and Global Standing in the 21st Century: Realities and Perceptions. 63-88. DOI: 10.4324/9781315675619  0.012
1997 Gilboa E, Roberts JE, Gotlib IH. The Effects of Induced and Naturally Occurring Dysphoric Mood on Biases in Self-evaluation and Memory Cognition and Emotion. 11: 65-82.  0.011
2014 Magen C, Gilboa E. Communicating From Within the Shadows: The Israel Security Agency and the Media International Journal of Intelligence and Counterintelligence. 27: 485-508. DOI: 10.1080/08850607.2014.900293  0.01
2013 Gilboa E. The United States and the Arab Spring The Arab Spring Democracy and Security: Domestic and International Ramifications. 51-74. DOI: 10.4324/9780203539132  0.01
2011 Gilboa E, Shai N. Rebuilding public diplomacy: The case of Israel Diplomatic Studies. 6: 33-54.  0.01
1996 Gilboa E. The panama invasion revisited: lessons for the use of force in the post cold war era Political Science Quarterly. 110: 539-562.  0.01
1991 Gilboa E. The Intifada: Two Assessments Terrorism and Political Violence. 3: 108-116. DOI: 10.1080/09546559108427109  0.01
Hide low-probability matches.